Trial Profile
Retigabine in patients with partial seizures.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2011
Price :
$35
*
At a glance
- Drugs Retigabine (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.